EBAMED

EBAMED was founded in 2018, is headquartered in Geneva, Switzerland, and has $20.0M in recorded funding across 5 rounds.

Headquarters
Geneva
Founded
2018
Business Model
B2B
Total Funding
$20.0M
Last Round
$15.7M Series AJun 2023
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 5 investors for this company. The full record is or through the API.

About

EBAMed is a Geneva, Switzerland-based medical device company developing innovative image-guidance and proton-therapy solutions for the non-invasive, painless treatment of heart arrhythmias via external beam ablation. Building on preclinical research from its co-founder team on using protons for arrhythmia treatment, EBAMed aims to make proton therapy a practical, non-invasive alternative to current catheter-based cardiac ablation technologies, enabling treatment at an earlier stage of disease.

Summary

EBAMED is a Biotech company based in Geneva, Switzerland, founded in 2018. It has raised $20.0M in total across 5 rounds, most recently a $15.7M Series A round in Jun 2023. Investors include Venture Kick, Panakes Partners and European Innovation Council Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2023
$15.7M

Sign up to see all 5 events

Funding: Grant through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EBAMED on Indexed.vc
<a href="https://indexed.vc/companies/ebamed"><img src="https://indexed.vc/api/badge/company/ebamed" alt="EBAMED on Indexed.vc" width="260" height="76" /></a>